Rare Disease Discussions

Rare Disease Discussions

Peter Ciszewski, CheckRare

Episodes 191
Avg. Duration 21m
Activity Highly Active
Apple Rating 5.0 (3)
Since May 2020
Latest Episode Jun 2026

Outreach Signals

Open to Sponsors Features Guests

Publishing Details

Schedule
Weekly
Format
Episodic
Consistency
29%
Hosting
www.spreaker.com

Contact & Outreach

About This Podcast

News and clinical perspective including CME programs focused on rare diseases. CheckRare focuses on rare and neglected diseases.

Podcasting 2.0 Features

transcript

Explore Statistics

Recent Episodes

Growth Hormone Deficiency: Causes, Early Detection, and Treatment (Robert Rapaport, MD)

Jun 08, 2026 10m Transcript

Robert Rapaport, MD, Professor of Pediatric Endocrinology, and Director of the Comprehensive Growth Center at the Icahn School of Medicine, Mount Sinai Medical Center, New York City, discusses the…

Arginine Vasopressin Deficiency (AVP-D) Overview (Christopher Romero, MD)

Jun 03, 2026 19m Transcript

Christopher Romero, MD, a pediatric endocrinologist at Mount Sinai Medical Center, New York City, and Associate Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai discusses…

Systemic Mastocytosis: Recognition, Diagnosis, and Clinical Management

May 18, 2026 44m Transcript

This accredited continuing education program is supported by an educational grant from Blueprint Medicine. It provides timely and practical education on systemic mastocytosis (SM). To obtain CME…

Prader-Willi Syndrome: Clinical Features and Early Identification

Apr 24, 2026 1h 14m

Merlin G. Butler, MD, Medical Geneticist and Professor, Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, and one of the pioneers…

Diagnosis and Management of Plasminogen Deficiency

Mar 12, 2026 9m

Amol Sura, MD, Foster Center for Ocular Immunology, Dept of Ophthalmology, Duke University, Durham, North Carolina, discusses the diagnosis and management of plasminogen deficiency, a rare condition…

Submission of New Drug Application: Rusfertide for Polycythemia Vera

Feb 17, 2026 18m

Dinesh Patel, PhD, CEO of Protagonist Therapeutics, discusses the New Drug Application (NDA) submission to the US Food and Drug Administration (FDA) for rusfertide to treat adults with polycythemia…

Current Issues in Gene Therapies for Lysosomal Disorders

Dec 31, 2025 1h 46m

Shunji Tomatsu, MD, PhD, Professor and Head, Nemours Children’s Health, Delaware, USA; Alessandra d’Azzo, PhD, Emerita Faculty, Genetics, St. Jude Children’s Research Hospital, Tennessee, USA; Merve…

Theranostics and Lysosomal Disorders

Dec 31, 2025 1h 46m

Duarte C. Barral, PhD, Associate Professor, NOVA Medical School, NOVA University of Lisbon, Portugal; Nuno Raimundo, PhD, Associate Professor, Department of Cellular and Molecular Physiology; Penn…

Expanded Applications of AI in Lysosomal Disorders

Dec 31, 2025 2h 1m

Oral Alpan, MD, Immunologist, Amerimmune, Virginia, USA; Svenja Keller, PhD student, University of Zurich, Switzerland; Shoshana Revel-Vilk, MD, PhD, Director, Gaucher Unit & Pediatric…

Organoids and Lab-Grown Models in Lysosomal Disorders

Dec 31, 2025 1h 36m

Mia Horowitz, PhD, Tel Aviv University; Aitor Aguirre, PhD, Michigan State University, Michigan, USA; and Ying Sun, PhD, University of Cincinnati, discuss the use of organoid models in lysosomal…

Nanotechnology and Lysosomal Disorders

Dec 31, 2025 50m

Stephan Stern, PhD, DABT, Director of Research and Development, Nanotechnology Characterization Lab (NCL), Frederick National Laboratory for Cancer Research, Maryland, USA; and Ruben Boado, PhD,…

AI in Medicine: Transforming the Landscape of Tissue-Based Diagnostics

Dec 31, 2025 52m

Behzad Najafian, MD, Professor, Department of Laboratory Medicine & Pathology, Department of Medicine at the University of Washington, Washington, USA discusses the use of artificial intelligence…

Chapter 8: Gene Therapy Discussion and Q&A

Dec 22, 2025 4m

Alan Beggs, PhDDirector of the Manton Center for Orphan Disease ResearchSir Edwin and Lady Manton Professor of Pediatrics, Boston Children's HospitalHarvard Medical School, Boston, MA, USA Julie A.…

Chapter 7: Changes in Gene Therapy Programs to Lessons Learned from Recent Trials

Dec 22, 2025 5m

Julie A. Parsons, MD Haberfield Endowed Chair in Pediatric Neuromuscular DisordersProfessor of Clinical Pediatrics and NeurologyUniversity of Colorado School of Medicine, Children's Hospital…

Chapter 6: Understanding and Preparing Risk Factors Associated With AAV Gene Therapies

Dec 22, 2025 6m

Julie A. Parsons, MDHaberfield Endowed Chair in Pediatric Neuromuscular DisordersProfessor of Clinical Pediatrics and NeurologyUniversity of Colorado School of Medicine, Children's Hospital…

Chapter 5: Factors Impacting Safety and Efficacy of AAV Mediated Gene Therapies

Dec 22, 2025 5m

Julie A. Parsons, MDHaberfield Endowed Chair in Pediatric Neuromuscular DisordersProfessor of Clinical Pediatrics and NeurologyUniversity of Colorado School of Medicine, Children's Hospital…

Ch 4: Clinical Safety and Efficacy Observed in AAV Mediated Gene Therapy Programs in DMD, SMA, XLMTM

Dec 22, 2025 4m

Julie A. Parsons, MD Haberfield Endowed Chair in Pediatric Neuromuscular DisordersProfessor of Clinical Pediatrics and NeurologyUniversity of Colorado School of Medicine, Children's Hospital…

Ch 3: Mitigation Strategies to Address the Challenges in the Development of Gene Therapy Programs

Dec 22, 2025 5m

Alan Beggs, PhDDirector of the Manton Center for Orphan Disease ResearchSir Edwin and Lady Manton Professor of Pediatrics, Boston Children's HospitalHarvard Medical School, Boston, MA, USAThe…

Chapter 2: AAV Mediated Gene Therapies

Dec 22, 2025 5m

Alan Beggs, PhDDirector of the Manton Center for Orphan Disease ResearchSir Edwin and Lady Manton Professor of Pediatrics, Boston Children's HospitalHarvard Medical School, Boston, MA, USA Julie A.…

Chapter 1: Introduction to Gene Directed Therapies

Dec 22, 2025 4m

Drs. Beggs and Parsons discuss the current status of gene therapies in rare neuromuscular disorders in this eight-part podcast series. This is derived from the symposium that was presented at the MDA…

Frequently Asked Questions

How many episodes does Rare Disease Discussions have?

Rare Disease Discussions has published 191 episodes since May 2020, covering topics in Health & Fitness, Medicine.

Is Rare Disease Discussions still active?

Rare Disease Discussions is currently highly active with new episodes weekly. Average episode length is 21m.

How do I contact Rare Disease Discussions for sponsorship or guest appearances?

Sign up on Grep.FM to access contact details for Rare Disease Discussions, including email and social media links.

Similar Podcasts